News Image

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Provided By GlobeNewswire

Last update: Nov 4, 2025

Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024

Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% on an adjusted pro forma basis versus Q3 2024

Read more at globenewswire.com

NEURONETICS INC

NASDAQ:STIM (12/10/2025, 4:30:01 PM)

After market: 1.31 -0.02 (-1.5%)

1.33

+0.04 (+3.1%)



Find more stocks in the Stock Screener

Follow ChartMill for more